John Ayuk Selected Research

John Ayuk Research Topics

Disease

11	Acromegaly 01/2021 - 09/2002
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 03/2005
4	Neoplasms (Cancer) 01/2021 - 01/2009
4	Hypopituitarism (Sheehan's Syndrome) 01/2018 - 11/2004
3	Prolactinoma (Prolactinomas) 01/2018 - 11/2017
2	Craniopharyngioma (Craniopharyngiomas) 01/2022 - 04/2016
2	Adenoma (Adenomas) 01/2018 - 01/2017
2	Pituitary Diseases (Disease, Anterior Pituitary) 06/2010 - 01/2009
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2022
1	Coma (Comas) 05/2022
1	Seizures (Absence Seizure) 05/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypertension (High Blood Pressure) 12/2019
1	Hypotension (Low Blood Pressure) 12/2019
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Melanoma (Melanoma, Malignant) 03/2019
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Adrenal incidentaloma 03/2019
1	Injection Site Reaction 08/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Hypertensive Crisis 01/2018
1	Hyperprolactinemia 01/2018
1	Diabetes Insipidus 01/2018
1	Hypothyroidism 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Infarction (Infarctions) 04/2016
1	Flushing 02/2016
1	Short Bowel Syndrome 04/2014
1	Hypocalcemia 04/2014
1	Renal Insufficiency (Renal Failure) 03/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2012
1	Stroke (Strokes) 03/2012
1	Acidosis 12/2011
1	Primary Hyperparathyroidism 10/2010
1	Pituitary ACTH Hypersecretion 06/2010
1	Central Nervous System Neoplasms 01/2009
1	Vascular System Injuries 01/2009
1	Pituitary Apoplexy 12/2004
1	Glucose Intolerance 09/2002

Drug/Important Bio-Agent (IBA)

7	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 04/2009
5	Growth Hormone (Somatotropin)IBA 01/2021 - 04/2009
5	Hormones (Hormone)IBA 03/2019 - 06/2010
4	ProlactinIBA 01/2018 - 11/2017
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 09/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 11/2004
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018 - 06/2010
3	MagnesiumIBA 04/2014 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 09/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 06/2010
2	GonadotropinsIBA 11/2016 - 06/2010
2	Octreotide (Sandostatin)FDA LinkGeneric 02/2016 - 03/2004
2	pegvisomant FDA LinkGeneric 04/2009 - 11/2004
1	LithiumIBA 05/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2022
1	Protons (Proton)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 12/2019
1	NormetanephrineIBA 12/2019
1	Antisense OligonucleotidesIBA 08/2018
1	ATL 227446IBA 08/2018
1	Phentolamine (Z-Max)FDA LinkGeneric 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Parathyroid Hormone (Parathormone)IBA 10/2010
1	Pharmaceutical PreparationsIBA 04/2009
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 11/2004

Therapy/Procedure

12	Radiotherapy 01/2022 - 03/2004
7	Therapeutics 12/2019 - 09/2002
1	Adrenalectomy 03/2019
1	Adjuvant Radiotherapy 01/2018
1	Duration of Therapy 01/2018
1	Conservative Treatment 12/2004